Search
Close this search box.

Key highlights of the Oncomine Comprehensive Assay Plus

Key highlights of the Oncomine Comprehensive Assay Plus

  • Profile 500+ unique genes for single gene and multiple gene biomarker insights
  • Detect single gene biomarkers from all variant types including SNVs, indels, CNVs, known and novel fusions, and splice variants
  • Analyze complex multi-gene biomarkers for mutational signatures, including tumour mutational burden (TMB) microsatellite instability (MSI) for immunotherapy research
  • Detect deficiencies in homology recombination repair (HRR) by assessing variants in 42 HRR pathway genes and genomic instability with sample level loss of heterozygosity (LOH)
  • Detect complex loss of function variants (including gene-level LOH) in key HRR genes, including BRCA1 and BRCA2
  Oncomine Comprehensive Plus Assay/Gene list(N=233)
Hot Spot Genes CNV Gain Genes Copy Number Variation and Hotspot Genes Gene Fusions (Inter- and Intra-genic)
ACVR1 NTRK2 GLI1 ABCB1 ABL1 H3-3A PIK3R2 CDK4 MAX AKT1 MYB
ATP1A1 NUP93 GNA11 CTNND2 ABL2 H3-3B PIM1 CDK6 MDM4 AKT2 MYBL1
BCR PAX5 GNAQ DDR1 AKT1 IDH2 PLCG1 CHD4 MECOM AKT3 NOTCH1
BMP5 PIK3CD H2BC5 EMSY AKT2 IKBKB PPP2R1A DDR2 MEF2B ALK NOTCH2
BTK PIK3CG H3C2 FGF19 AKT3 IL7R PPP6C EGFR MET AR NOTCH3
CACNA1D PTPRD HIF1A FGF23 ALK KDR PRKACA EIF1AX MITF BRAF NRG1
CD79B RGS7 HRAS FGF3 AR KIT PTPN11 ERBB2 MPL BRCA1 NTRK1
CSF1R RHOA IDH1 FGF4 ARAF KLF5 PXDNL ERBB3 MTOR CDKN2A NTRK2
CTNNB1 RPL10 IL6ST FGF9 AURKA KRAS RAC1 ERBB4 MYC EGFR NTRK3
CUL1 SIX1 IRF4 FYN AURKC MAGOH RAF1 ESR1 MYCN ERBB2 NUTM1
CYSLTR2 SIX2 IRS4 GLI3 AXL MAP2K1 RARA EZH2 MYD88 ERBB4 PIK3CA
DGCR8 SNCAIP KLF4 IGF1R BCL2 MAPK1 RET FAM135B NFE2L2 ERG PIK3CB
DROSHA SOS1 KNSTRN MCL1 BCL2L12 TPMT RHEB FGFR1 NRAS ESR1 PPARG
E2F1 SOX2 MAP2K2 MDM2 BCL6 U2AF1 RICTOR FGFR2 NTRK1 ETV1 PRKACA
EPAS1 SRSF2 MED12 MYCL BRAF USP8 RIT1 FGFR3 NTRK3 ETV4 PRKACB
FGF7 STAT5B MYOD1 RPS6KB1 CARD11 XPO1 ROS1 FGFR4 PCBP1 ETV5 RAF1
FOXL2 TAF1 NSD2 RPTOR CBL ZNF217 SETBP1 FLT3 PDGFRA FGFR1 RARA
FOXO1 TGFBR1 NT5C2 YAP1 CCND1 ZNF429 SF3B1 FLT4 PDGFRB FGFR2 RELA
TSHR TRRAP WAS YES1 CCND2 STAT6 SLCO1B3 FOXA1 PIK3C2B FGFR3 RET
CCND3 TERT SMC1A GATA2 PIK3CA MAP3K8 ROS1
CCNE1 TOP1 SMO GNAS PIK3CB MET RSPO2
SPOP SRC STAT3 MTAP RSPO3
STAT6 TFE3
TERT TFEB
YAP1
Platform:       Ion Gene Studio S5 Systems Specimen:      Formalin-fixed, paraffin-embedded (FFPE) tissue    
Oncomine Comprehensive Plus Assay/Gene list-CNV
CNV Loss and CDS (n=206) CDS Only Genes(n=21) TMB only genes (n=86)
ABRAXAS1 CDKN2C FANCM MUTYH RAD54L* CALR A1CF OR2T4
ACVR1B CHEK1* FAT1 NBN* RASA1 CIITA ACSM2B OR2W3
ACVR2A CHEK2* FBXW7 NCOR1 RASA2 CYP2D6 ADAM18 OR4A15
ADAMTS12 CIC FUBP1 NF1 RB1 ERCC5 ANO4 OR4C15
ADAMTS2 CREBBP GATA3 NF2 RBM10 FAS ARMC4 OR4C6
AMER1 CSMD3 GNA13 NOTCH1 RECQL4 ID3 BRINP3 OR4M1
APC CTCF GPS2 NOTCH2 RNASEH2A KLHL13 C6 OR4M2
ARHGAP35 CTLA4 HDAC2 NOTCH3 RNASEH2B MTUS2 C8A OR5D18
ARID1A CUL3 HDAC9 NOTCH4 RNF43 PSMB10 C8B OR5F1
ARID1B CUL4A HLA-A PALB2* RPA1 PSMB8 CANX OR5L1
ARID2 CUL4B HLA-B PARP1 RUNX1 PSMB9 CASR OR5L2
ARID5B CYLD HNF1A PARP2 SDHA RNASEH2C CD163 OR6F1
ASXL1 CYP2C9 INPP4B PARP3 SDHB RPL22 CNTN6 OR8H2
ASXL2 DAXX JAK1 PARP4 SDHD RPL5 CNTNAP4 OR8I2
ATM* DDX3X JAK2 PBRM1 SETD2 RUNX1T1 CNTNAP5 OR8U1
ATR DICER1 JAK3 PDCD1 SLX4 SDHC COL11A1 ORC4
ATRX DNMT3A KDM5C PDCD1LG2 SMAD2 SOCS1 DCAF4L2 PAK5
AXIN1 DOCK3 KDM6A PDIA3 SMAD4 STAT1 DCDC1 PCDH17
AXIN2 DPYD KEAP1 PGD SMARCA4 TMEM132D GALNT17 PDE1A
B2M DSC1 KMT2A PHF6 SMARCB1 UGT1A1 GPR158 PDE1C
BAP1 DSC3 KMT2B PIK3R1 SOX9 ZBTB20 GRID2 PLXDC2
BARD1* ELF3 KMT2C PMS1 SPEN HCN1 POM121L12
BCOR ENO1 KMT2D PMS2 STAG2 HLA-C PPFIA2
BLM* EP300 LARP4B POLD1* STK11 KCND2 RBP3
BMPR2 EPCAM LATS1 POLE* SUFU KCNH7 REG1A
BRCA1* EPHA2 LATS2 POT1 TAP1 KEL REG1B
BRCA2* ERAP1 MAP2K4 PPM1D TAP2 KIR3DL1 REG3A
BRIP1* ERAP2 MAP2K7 PPP2R2A* TBX3 KRTAP2-1 REG3G
CASP8 ERCC2 MAP3K1 PRDM1 TCF7L2 KRTAP6-2 RPTN
CBFB ERCC4 MAP3K4 PRDM9 TET2 LRRC7 RUNDC3B
CD274 ERRFI1 MAPK8 PRKAR1A TGFBR2 MARCO SH3RF2
CD276 ETV6 MEN1 PTCH1 TNFAIP3 NLRC5 SLC15A2
CDC73 FANCA MGA PTEN* TNFRSF14 NOL4 SLC8A1
CDH1 FANCC MLH1 PTPRT TP53* NRXN1 SYT10
CDH10 FANCD2 MLH3 RAD50 TP63 NYAP2 SYT16
CDK12* FANCE MRE11 RAD51 TPP2 OR10G8 TAPBP
CDKN1A FANCF MSH2 RAD51B* TSC1 OR2G6 TPTE
CDKN1B FANCG MSH3 RAD51C* TSC2 OR2L13 TRHDE
CDKN2A FANCI MSH6 RAD51D* USP9X OR2L2 TRIM48
CDKN2B FANCL* MTAP RAD52 VHL OR2L8 TRIM51
ZRSR2 ZMYM3 ZFHX3 XRCC3 WT1 OR2M3> ZIM3>
XRCC2 OR2T3 ZNF479
OR2T33 ZNF536
 

The Oncomine™ Comprehensive Assay Plus can be used for all Cancers, including:

Early Cancers

The Oncomine™ Comprehensive Assay Plus can help identify optimal treatment options following initial diagnosis. This helps avoid costs and side effects from potentially ineffective drugs.

Widespread Advanced Cancers

The Oncomine™ Comprehensive Assay Plus can identify a broad range of additional therapeutic options for patients who have exhausted conventional treatments such as chemotherapy.

Rare or Unknown Cancers

Treatment decisions for rare unknown cancers are challenging for your oncologist because of a lack of established therapeutic protocols. The Oncomine™ Comprehensive Assay Plus is ideally suited for the analysis of such cases enabling the precise matching of these tumours to the most appropriate therapy.

Difficult to Treat Cancers

The Oncomine™ Comprehensive Assay Plus can be used for re-testing to identify new genetic changes acquired following relapse and allow the new mutations to be directly matched to a new set of targeted therapies. Our DNA genetic cancer test can help guide your doctors on whether you are able to join a clinical trial. The genetic data from a clinical trial may be used in your individual care, improving the health services you and others receive and further research.

Cell Digital

Typically replies within 15 minutes

Hello, Welcome to the Cell Digital Laboratory. Please click below button for chatting me through Telegram.

0 Item |
View Cart
Scroll to Top